Report Detail
Global Cardiovascular Interventional Product Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
- RnM4628633 |
- 26 September, 2025 |
- Global |
- 139 Pages |
- GIR |
- Medical Devices & Consumables
According to our (Global Info Research) latest study, the global Cardiovascular Interventional Product market size was valued at US$ 11560 million in 2024 and is forecast to a readjusted size of USD 15880 million by 2031 with a CAGR of 4.7% during review period.
Cardiovascular interventional products are medical devices used in the diagnosis and treatment of cardiovascular diseases through minimally invasive procedures. These products are designed to address conditions like coronary artery disease, heart valve problems, peripheral artery disease, and other heart-related issues. Common examples include stents, catheters, balloons, guidewires, and embolization devices, which are used during interventional procedures such as angioplasty, stent placement, and catheter-based diagnostics. These products help to restore blood flow, open blocked arteries, and manage other complications without the need for traditional open-heart surgery, making them less invasive and reducing recovery times for patients.
The cardiovascular interventional product market is primarily driven by the rising prevalence of cardiovascular diseases (CVDs), such as coronary artery disease, heart failure, and peripheral artery disease, which require advanced interventional treatments. As the global population ages and lifestyle-related risk factors like smoking, obesity, and sedentary habits increase, the demand for cardiovascular procedures such as angioplasty, stent implantation, and other minimally invasive treatments has surged. Additionally, advancements in medical technology, such as the development of more durable stents, better imaging systems, and improved catheters, have made these interventions safer, more effective, and less invasive, further fueling market growth. Increasing healthcare investments, better healthcare access, and growing awareness about the importance of early diagnosis and treatment are also contributing to the expansion of the market.However, the cardiovascular interventional product market faces several challenges, including the high cost of advanced medical devices, which can limit their adoption, particularly in developing countries or in healthcare systems with constrained budgets. The complexity of some interventional procedures, requiring highly specialized training and expertise, also presents a barrier to widespread usage. Additionally, complications related to stent restenosis, thrombosis, and other post-intervention issues continue to pose challenges, despite advancements in technology. The market is also impacted by the increasing regulatory scrutiny and stringent approval processes for new cardiovascular products, which can slow down innovation and increase the time-to-market for new devices.
Global key players of Cardiovascular Interventional Product include Boston Scientific, Abbott Laboratories, Medtronic plc, TERUMO CORPORATION and NIPRO, etc. Top five players occupy for a share about 75%. North America is the largest market, with a share about 47%, followed by Japan and Europe. In terms of product, Coronary Stent is the largest segment, with a share over 62%. In terms of application, Angina is the largest market, with a share over 60%.
This report is a detailed and comprehensive analysis for global Cardiovascular Interventional Product market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Cardiovascular Interventional Product market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Cardiovascular Interventional Product market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Cardiovascular Interventional Product market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Cardiovascular Interventional Product market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cardiovascular Interventional Product
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cardiovascular Interventional Product market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Boston Scientific, Abbott Laboratories, Medtronic, TERUMO, NIPRO, B. Braun, Cook Medical, MicroPort, Lepu Medical, JW Medical Systems (JWMS), etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Cardiovascular Interventional Product market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Coronary Stent
PTCA Balloon Catheter
Guide Wire
Other
Market segment by Application
Angina
Miocardial Infarction
Other
Major players covered
Boston Scientific
Abbott Laboratories
Medtronic
TERUMO
NIPRO
B. Braun
Cook Medical
MicroPort
Lepu Medical
JW Medical Systems (JWMS)
Intecc
KANEKA
Sinomed
Lifetech
Gore Medical
Biotronik
Merit Medical
Cordis
ACOTEC
LifeTech Scientific Corporation
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Cardiovascular Interventional Product product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Cardiovascular Interventional Product, with price, sales quantity, revenue, and global market share of Cardiovascular Interventional Product from 2020 to 2025.
Chapter 3, the Cardiovascular Interventional Product competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cardiovascular Interventional Product breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Cardiovascular Interventional Product market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Cardiovascular Interventional Product.
Chapter 14 and 15, to describe Cardiovascular Interventional Product sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Cardiovascular Interventional Product Consumption Value by Type: 2020 Versus 2024 Versus 2031
- 1.3.2 Coronary Stent
- 1.3.3 PTCA Balloon Catheter
- 1.3.4 Guide Wire
- 1.3.5 Other
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Cardiovascular Interventional Product Consumption Value by Application: 2020 Versus 2024 Versus 2031
- 1.4.2 Angina
- 1.4.3 Miocardial Infarction
- 1.4.4 Other
- 1.5 Global Cardiovascular Interventional Product Market Size & Forecast
- 1.5.1 Global Cardiovascular Interventional Product Consumption Value (2020 & 2024 & 2031)
- 1.5.2 Global Cardiovascular Interventional Product Sales Quantity (2020-2031)
- 1.5.3 Global Cardiovascular Interventional Product Average Price (2020-2031)
2 Manufacturers Profiles
- 2.1 Boston Scientific
- 2.1.1 Boston Scientific Details
- 2.1.2 Boston Scientific Major Business
- 2.1.3 Boston Scientific Cardiovascular Interventional Product Product and Services
- 2.1.4 Boston Scientific Cardiovascular Interventional Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.1.5 Boston Scientific Recent Developments/Updates
- 2.2 Abbott Laboratories
- 2.2.1 Abbott Laboratories Details
- 2.2.2 Abbott Laboratories Major Business
- 2.2.3 Abbott Laboratories Cardiovascular Interventional Product Product and Services
- 2.2.4 Abbott Laboratories Cardiovascular Interventional Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.2.5 Abbott Laboratories Recent Developments/Updates
- 2.3 Medtronic
- 2.3.1 Medtronic Details
- 2.3.2 Medtronic Major Business
- 2.3.3 Medtronic Cardiovascular Interventional Product Product and Services
- 2.3.4 Medtronic Cardiovascular Interventional Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.3.5 Medtronic Recent Developments/Updates
- 2.4 TERUMO
- 2.4.1 TERUMO Details
- 2.4.2 TERUMO Major Business
- 2.4.3 TERUMO Cardiovascular Interventional Product Product and Services
- 2.4.4 TERUMO Cardiovascular Interventional Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.4.5 TERUMO Recent Developments/Updates
- 2.5 NIPRO
- 2.5.1 NIPRO Details
- 2.5.2 NIPRO Major Business
- 2.5.3 NIPRO Cardiovascular Interventional Product Product and Services
- 2.5.4 NIPRO Cardiovascular Interventional Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.5.5 NIPRO Recent Developments/Updates
- 2.6 B. Braun
- 2.6.1 B. Braun Details
- 2.6.2 B. Braun Major Business
- 2.6.3 B. Braun Cardiovascular Interventional Product Product and Services
- 2.6.4 B. Braun Cardiovascular Interventional Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.6.5 B. Braun Recent Developments/Updates
- 2.7 Cook Medical
- 2.7.1 Cook Medical Details
- 2.7.2 Cook Medical Major Business
- 2.7.3 Cook Medical Cardiovascular Interventional Product Product and Services
- 2.7.4 Cook Medical Cardiovascular Interventional Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.7.5 Cook Medical Recent Developments/Updates
- 2.8 MicroPort
- 2.8.1 MicroPort Details
- 2.8.2 MicroPort Major Business
- 2.8.3 MicroPort Cardiovascular Interventional Product Product and Services
- 2.8.4 MicroPort Cardiovascular Interventional Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.8.5 MicroPort Recent Developments/Updates
- 2.9 Lepu Medical
- 2.9.1 Lepu Medical Details
- 2.9.2 Lepu Medical Major Business
- 2.9.3 Lepu Medical Cardiovascular Interventional Product Product and Services
- 2.9.4 Lepu Medical Cardiovascular Interventional Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.9.5 Lepu Medical Recent Developments/Updates
- 2.10 JW Medical Systems (JWMS)
- 2.10.1 JW Medical Systems (JWMS) Details
- 2.10.2 JW Medical Systems (JWMS) Major Business
- 2.10.3 JW Medical Systems (JWMS) Cardiovascular Interventional Product Product and Services
- 2.10.4 JW Medical Systems (JWMS) Cardiovascular Interventional Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.10.5 JW Medical Systems (JWMS) Recent Developments/Updates
- 2.11 Intecc
- 2.11.1 Intecc Details
- 2.11.2 Intecc Major Business
- 2.11.3 Intecc Cardiovascular Interventional Product Product and Services
- 2.11.4 Intecc Cardiovascular Interventional Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.11.5 Intecc Recent Developments/Updates
- 2.12 KANEKA
- 2.12.1 KANEKA Details
- 2.12.2 KANEKA Major Business
- 2.12.3 KANEKA Cardiovascular Interventional Product Product and Services
- 2.12.4 KANEKA Cardiovascular Interventional Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.12.5 KANEKA Recent Developments/Updates
- 2.13 Sinomed
- 2.13.1 Sinomed Details
- 2.13.2 Sinomed Major Business
- 2.13.3 Sinomed Cardiovascular Interventional Product Product and Services
- 2.13.4 Sinomed Cardiovascular Interventional Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.13.5 Sinomed Recent Developments/Updates
- 2.14 Lifetech
- 2.14.1 Lifetech Details
- 2.14.2 Lifetech Major Business
- 2.14.3 Lifetech Cardiovascular Interventional Product Product and Services
- 2.14.4 Lifetech Cardiovascular Interventional Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.14.5 Lifetech Recent Developments/Updates
- 2.15 Gore Medical
- 2.15.1 Gore Medical Details
- 2.15.2 Gore Medical Major Business
- 2.15.3 Gore Medical Cardiovascular Interventional Product Product and Services
- 2.15.4 Gore Medical Cardiovascular Interventional Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.15.5 Gore Medical Recent Developments/Updates
- 2.16 Biotronik
- 2.16.1 Biotronik Details
- 2.16.2 Biotronik Major Business
- 2.16.3 Biotronik Cardiovascular Interventional Product Product and Services
- 2.16.4 Biotronik Cardiovascular Interventional Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.16.5 Biotronik Recent Developments/Updates
- 2.17 Merit Medical
- 2.17.1 Merit Medical Details
- 2.17.2 Merit Medical Major Business
- 2.17.3 Merit Medical Cardiovascular Interventional Product Product and Services
- 2.17.4 Merit Medical Cardiovascular Interventional Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.17.5 Merit Medical Recent Developments/Updates
- 2.18 Cordis
- 2.18.1 Cordis Details
- 2.18.2 Cordis Major Business
- 2.18.3 Cordis Cardiovascular Interventional Product Product and Services
- 2.18.4 Cordis Cardiovascular Interventional Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.18.5 Cordis Recent Developments/Updates
- 2.19 ACOTEC
- 2.19.1 ACOTEC Details
- 2.19.2 ACOTEC Major Business
- 2.19.3 ACOTEC Cardiovascular Interventional Product Product and Services
- 2.19.4 ACOTEC Cardiovascular Interventional Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.19.5 ACOTEC Recent Developments/Updates
- 2.20 LifeTech Scientific Corporation
- 2.20.1 LifeTech Scientific Corporation Details
- 2.20.2 LifeTech Scientific Corporation Major Business
- 2.20.3 LifeTech Scientific Corporation Cardiovascular Interventional Product Product and Services
- 2.20.4 LifeTech Scientific Corporation Cardiovascular Interventional Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.20.5 LifeTech Scientific Corporation Recent Developments/Updates
3 Competitive Environment: Cardiovascular Interventional Product by Manufacturer
- 3.1 Global Cardiovascular Interventional Product Sales Quantity by Manufacturer (2020-2025)
- 3.2 Global Cardiovascular Interventional Product Revenue by Manufacturer (2020-2025)
- 3.3 Global Cardiovascular Interventional Product Average Price by Manufacturer (2020-2025)
- 3.4 Market Share Analysis (2024)
- 3.4.1 Producer Shipments of Cardiovascular Interventional Product by Manufacturer Revenue ($MM) and Market Share (%): 2024
- 3.4.2 Top 3 Cardiovascular Interventional Product Manufacturer Market Share in 2024
- 3.4.3 Top 6 Cardiovascular Interventional Product Manufacturer Market Share in 2024
- 3.5 Cardiovascular Interventional Product Market: Overall Company Footprint Analysis
- 3.5.1 Cardiovascular Interventional Product Market: Region Footprint
- 3.5.2 Cardiovascular Interventional Product Market: Company Product Type Footprint
- 3.5.3 Cardiovascular Interventional Product Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Cardiovascular Interventional Product Market Size by Region
- 4.1.1 Global Cardiovascular Interventional Product Sales Quantity by Region (2020-2031)
- 4.1.2 Global Cardiovascular Interventional Product Consumption Value by Region (2020-2031)
- 4.1.3 Global Cardiovascular Interventional Product Average Price by Region (2020-2031)
- 4.2 North America Cardiovascular Interventional Product Consumption Value (2020-2031)
- 4.3 Europe Cardiovascular Interventional Product Consumption Value (2020-2031)
- 4.4 Asia-Pacific Cardiovascular Interventional Product Consumption Value (2020-2031)
- 4.5 South America Cardiovascular Interventional Product Consumption Value (2020-2031)
- 4.6 Middle East & Africa Cardiovascular Interventional Product Consumption Value (2020-2031)
5 Market Segment by Type
- 5.1 Global Cardiovascular Interventional Product Sales Quantity by Type (2020-2031)
- 5.2 Global Cardiovascular Interventional Product Consumption Value by Type (2020-2031)
- 5.3 Global Cardiovascular Interventional Product Average Price by Type (2020-2031)
6 Market Segment by Application
- 6.1 Global Cardiovascular Interventional Product Sales Quantity by Application (2020-2031)
- 6.2 Global Cardiovascular Interventional Product Consumption Value by Application (2020-2031)
- 6.3 Global Cardiovascular Interventional Product Average Price by Application (2020-2031)
7 North America
- 7.1 North America Cardiovascular Interventional Product Sales Quantity by Type (2020-2031)
- 7.2 North America Cardiovascular Interventional Product Sales Quantity by Application (2020-2031)
- 7.3 North America Cardiovascular Interventional Product Market Size by Country
- 7.3.1 North America Cardiovascular Interventional Product Sales Quantity by Country (2020-2031)
- 7.3.2 North America Cardiovascular Interventional Product Consumption Value by Country (2020-2031)
- 7.3.3 United States Market Size and Forecast (2020-2031)
- 7.3.4 Canada Market Size and Forecast (2020-2031)
- 7.3.5 Mexico Market Size and Forecast (2020-2031)
8 Europe
- 8.1 Europe Cardiovascular Interventional Product Sales Quantity by Type (2020-2031)
- 8.2 Europe Cardiovascular Interventional Product Sales Quantity by Application (2020-2031)
- 8.3 Europe Cardiovascular Interventional Product Market Size by Country
- 8.3.1 Europe Cardiovascular Interventional Product Sales Quantity by Country (2020-2031)
- 8.3.2 Europe Cardiovascular Interventional Product Consumption Value by Country (2020-2031)
- 8.3.3 Germany Market Size and Forecast (2020-2031)
- 8.3.4 France Market Size and Forecast (2020-2031)
- 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
- 8.3.6 Russia Market Size and Forecast (2020-2031)
- 8.3.7 Italy Market Size and Forecast (2020-2031)
9 Asia-Pacific
- 9.1 Asia-Pacific Cardiovascular Interventional Product Sales Quantity by Type (2020-2031)
- 9.2 Asia-Pacific Cardiovascular Interventional Product Sales Quantity by Application (2020-2031)
- 9.3 Asia-Pacific Cardiovascular Interventional Product Market Size by Region
- 9.3.1 Asia-Pacific Cardiovascular Interventional Product Sales Quantity by Region (2020-2031)
- 9.3.2 Asia-Pacific Cardiovascular Interventional Product Consumption Value by Region (2020-2031)
- 9.3.3 China Market Size and Forecast (2020-2031)
- 9.3.4 Japan Market Size and Forecast (2020-2031)
- 9.3.5 South Korea Market Size and Forecast (2020-2031)
- 9.3.6 India Market Size and Forecast (2020-2031)
- 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
- 9.3.8 Australia Market Size and Forecast (2020-2031)
10 South America
- 10.1 South America Cardiovascular Interventional Product Sales Quantity by Type (2020-2031)
- 10.2 South America Cardiovascular Interventional Product Sales Quantity by Application (2020-2031)
- 10.3 South America Cardiovascular Interventional Product Market Size by Country
- 10.3.1 South America Cardiovascular Interventional Product Sales Quantity by Country (2020-2031)
- 10.3.2 South America Cardiovascular Interventional Product Consumption Value by Country (2020-2031)
- 10.3.3 Brazil Market Size and Forecast (2020-2031)
- 10.3.4 Argentina Market Size and Forecast (2020-2031)
11 Middle East & Africa
- 11.1 Middle East & Africa Cardiovascular Interventional Product Sales Quantity by Type (2020-2031)
- 11.2 Middle East & Africa Cardiovascular Interventional Product Sales Quantity by Application (2020-2031)
- 11.3 Middle East & Africa Cardiovascular Interventional Product Market Size by Country
- 11.3.1 Middle East & Africa Cardiovascular Interventional Product Sales Quantity by Country (2020-2031)
- 11.3.2 Middle East & Africa Cardiovascular Interventional Product Consumption Value by Country (2020-2031)
- 11.3.3 Turkey Market Size and Forecast (2020-2031)
- 11.3.4 Egypt Market Size and Forecast (2020-2031)
- 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
- 11.3.6 South Africa Market Size and Forecast (2020-2031)
12 Market Dynamics
- 12.1 Cardiovascular Interventional Product Market Drivers
- 12.2 Cardiovascular Interventional Product Market Restraints
- 12.3 Cardiovascular Interventional Product Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Cardiovascular Interventional Product and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Cardiovascular Interventional Product
- 13.3 Cardiovascular Interventional Product Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Cardiovascular Interventional Product Typical Distributors
- 14.3 Cardiovascular Interventional Product Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Cardiovascular Interventional Product. Industry analysis & Market Report on Cardiovascular Interventional Product is a syndicated market report, published as Global Cardiovascular Interventional Product Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Cardiovascular Interventional Product market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
